A traditional Chinese medicine composition for primary liver cancer and its application

Abstract

The invention provides a traditional Chinese medicine composition for primary liver cancer and its application. The traditional Chinese medicine composition comprises the following medicinal materials in parts by weight: 1-30 parts of ginkgo biloba, 1-20 parts of wood butterfly, 1-20 parts of sophora flavescens, and 1-10 parts of licorice. Pharmacological tests show that the traditional Chinese medicine composition of the invention has significant inhibitory effect on the growth of transplanted tumors of human liver cancer (Hep 3B and Huh7).

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine and medicine, and particularly relates to a traditional Chinese medicine composition for primary liver cancer and its application. Background technique [0002] Primary liver cancer (Primary Carcinoma of Liver, PLC) is a malignant tumor that occurs in hepatocytes or intrahepatic bile duct cells, of which hepatocellular carcinoma accounts for the vast majority of primary liver cancers. Primary liver cancer is one of the most common and harmful malignant tumors in my country and even in the world. In recent years, the incidence of primary liver cancer has been increasing worldwide, and its morbidity and mortality ranks fifth and third among malignant tumors. [0003] Modern medical treatment of primary liver cancer mainly selects the treatment plan according to the stage of liver cancer. The treatment mainly includes: surgical treatment (hepatectomy, liver transplantation), abl...

AI Technical Summary

Problems solved by technology

Therefore, the clinical treatment needs of primary liver cancer are far from being met.

Images